Experimental Therapeutics in Treatment-Resistant Major Depressive Disorder-Reference-Cited by-同舟云学术

Experimental Therapeutics in Treatment-Resistant Major Depressive Disorder

Published:2021-02 Issue: Volume:Volume 13 Page:181-196
ISSN:1179-1454
Container-title:Journal of Experimental Pharmacology
language:en
Short-container-title:JEP

Author:

Kaur Mandeep,Sanches Marsal

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,Molecular Medicine

Reference98 articles.

1. GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789–1858.

2. Center for Behavioral Health Statistics and Quality. 2017 National Survey on Drug Use and Health: Methodological Summary and Definitions. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2018.

3. American Psychiatric Association. Depressive disorders. In: Diagnostic and Statistical Manual of Mental Disorders. 5th ed. 2013.

4. Treatment resistant depression: A multi-scale, systems biology approach

5. Genetics and genomics of psychiatric disease

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Depression clinical trials worldwide: a systematic analysis of the ICTRP and comparison with ClinicalTrials.gov;Translational Psychiatry;2024-07-31

2. Exploring Esketamine's Therapeutic Outcomes as an FDA-Designated Breakthrough for Treatment-Resistant Depression and Major Depressive Disorder With Suicidal Intent: A Narrative Review;Cureus;2024-02-10

3. Suicide‐specific mortality among patients with treatment‐resistant major depressive disorder, major depressive disorder with prior suicidal ideation or suicide attempts, or major depressive disorder alone;Brain and Behavior;2023-07-21

4. Hypothalamo-Pituitary-Adrenal Axis in Depressive Disorders and Treatment Resistance;Psikhiatriya;2023-03-03

5. Reduced anhedonia following internet-based cognitive-behavioral therapy for depression is mediated by enhanced reward circuit activation;Psychological Medicine;2022-06-17